Trials / Conditions / Relapsed Myelodysplastic Syndromes
Relapsed Myelodysplastic Syndromes
3 registered clinical trials studyying Relapsed Myelodysplastic Syndromes.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS NCT06846606 | Auron Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies NCT04891757 | Foghorn Therapeutics Inc. | Phase 1 |
| Unknown | Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Follow NCT03091933 | Ciusss de L'Est de l'Île de Montréal | Phase 1 / Phase 2 |